Dartmouth researchers have identified nine traits that are not dependent on P values to predict single nucleotide polymorphisms (SNP) reproducibility in genome-wide association studies (GWAS) and reduce false positives
Casey Greene, PhD, an assistant professor of genetics at Dartmouth’s Geisel School of Medicine, has been selected for a highly competitive award from the Gordon and Betty Moore Foundation to support his work to bring the power of big data into the biology lab.
An article published in the journal Science provides support for a new—and still controversial—understanding of the immune system.
Dartmouth researchers have found that African American women are 55 percent less likely to receive breast reconstruction after mastectomy regardless of where they received their care.
Geisel post-doctoral researcher Elaina M. Melton, PhD, has received a prestigious NIH fellowship for emerging scientists that will support her research on two cholesterol-related diseases, atherosclerosis and xanthomatosis.
A highly competitive grant from the Burroughs Wellcome Fund will lay the foundation for better treatments for invasive fungal infections.
Doctors trained in locations with less intensive (and expensive) practice patterns appear to consistently be better at making clinical decisions that spare patients unnecessary and excessive medical care, according to a new study in JAMA Internal Medicine.
Dartmouth researchers explored the type and number of connections in transcription factor networks (TFNs) to evaluate the role assortativity plays on robustness in a study published in PLOS Computational Biology in August. The study found that the assortativity signature contributes to a network’s resilience against mutations.
Recent growth in health care spending for commercially insured individuals is due primarily to increases in prices for medical services, rather than increased use, according to a new study led by researchers at The Dartmouth Institute for Health Policy & Clinical Practice, published today in the American Journal of Managed Care.
More than 40 percent of Social Security Disability Insurance (SSDI) recipients take opioid pain relievers, while the prevalence of chronic opioid use is over 20 percent and rising, reports a study in the September issue of Medical Care.